News

Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
Eli Lilly will increase the UK price of its Mounjaro treatment by 170% to match European markets. Despite Novo Nordisk's ...
MOUNJARO prices in the UK could double as the manufacturer will next month hike the rate it charges pharmacies for the fat ...
The current list price in the UK for Lilly’s Mounjaro ranges from £92 ($124.89) to £122 a month, depending on the dose. This will increase to between £133 and £330 from Sept. 1, with the US drugmaker ...
A sweeping analysis of global studies reveals that stopping weight loss drugs, including well-known treatments like Ozempic and Wegovy, often triggers a rapid return of lost pounds.
There is zero evidence that ​​semaglutides can increase the size of your crown jewels. What may happen is that as you lose ...
Novo Nordisk (NYSE: NVO) is quite the divisive stock among both investors and analysts these days. Although its high-profile ...
Novo Nordisk faces challenges but offers growth potential through a weight loss pill and global expansion. Read more on why ...
New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an increased risk of rare eye conditions.
This article covers key health news including Primary Health Properties securing a takeover bid for Assura, Novo Nordisk's ...
Enthusiasm for its weight loss medications is intensifying, and several companies are preparing oral formulations.